Birdwatch Archive

Birdwatch Note Rating

2024-05-06 20:35:09 UTC - HELPFUL

Rated by Participant: 98F9195097F783649D10DA3B3ECE1B58EC7CFC49FD6B8F9E975290647EF8795B
Participant Details

Original Note:

Der Widerruf erfolgte auf Antrag von AstraZeneca selbst: "Auf Antrag des Zulassungsinhabers wird die durch den Beschluss C(2021) 698(final) vom 29. Januar 2021 erteilte Zulassung des Arzneimittels "Vaxzevria - COVID‑19‑Impfstoff (ChAdOx1‑S [rekombinant])" widerrufen." https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_de.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1787458723532665059
  • participantId -
  • raterParticipantId - 98F9195097F783649D10DA3B3ECE1B58EC7CFC49FD6B8F9E975290647EF8795B
  • createdAtMillis - 1715027709693
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 178745872353266505998F9195097F783649D10DA3B3ECE1B58EC7CFC49FD6B8F9E975290647EF8795B